TERATOMA BENIGN

This adverse event was reported 54 times

These drugs are most commonly taken by patients reporting TERATOMA BENIGN:

# Drug Count
0 CISPLATIN 23
1 ETOPOSIDE 22
2 BLEOMYCIN SULFATE 19
3 BLEOMYCIN 13
4 QUETIAPINE 10
5 SERTRALINE 9
6 FOLIC ACID 5
7 PACLITAXEL 5
8 GEMCITABINE HYDROCHLORIDE 4
9 OXALIPLATIN 4
See all common drugs associated with TERATOMA BENIGN

TERATOMA BENIGN is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PLATINUM 1 0.0019
1 BLEOMYCIN SULFATE 19 0.0018
2 ETOPOSIDE 22 0.0003
3 CISPLATIN 23 0.0003
4 AMOXICILLIN AND CLAVULANATE POTASSIUM 1 0.0002
5 ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE 1 0.0002
6 ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE 1 0.0002
7 FLUOCINONIDE TOPICAL SOLUTION USP, 0.05% 1 0.0002
8 IFOSFAMIDE FOR INJECTION 3 0.0001
9 GEMCITABINE HYDROCHLORIDE 4 0.0001
See all drugs enriched for association with TERATOMA BENIGN

TERATOMA BENIGN is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Topoisomerase Inhibitor [EPC] 22 0.0003
1 beta Lactamase Inhibitor [EPC] 1 0.0002
2 Platinum-based Drug [EPC] 27 0.0001
3 Progesterone [EPC] 1 0.0000
4 Leukotriene Receptor Antagonist [EPC] 1 0.0000
5 Microtubule Inhibitor [EPC] 5 0.0000
6 Atypical Antipsychotic [EPC] 10 0.0000
7 Vitamin D [EPC] 5 0.0000
8 Vitamin B12 [EPC] 5 0.0000
9 Calcineurin Inhibitor Immunosuppressant [EPC] 2 0.0000
See all drug classes enriched for association with TERATOMA BENIGN